Skip to main navigation Skip to search Skip to main content

Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants

  • Arasu Balasubramaniyam
  • , Emma Ryan
  • , Dallas Brown
  • , Therwa Hamza
  • , William Harrison
  • , Michael Gan
  • , Rajeshwer S. Sankhala
  • , Wei Hung Chen
  • , Elizabeth J. Martinez
  • , Jaime L. Jensen
  • , Vincent Dussupt
  • , Letzibeth Mendez-Rivera
  • , Sandra Mayer
  • , Jocelyn King
  • , Nelson L. Michael
  • , Jason Regules
  • , Shelly Krebs
  • , Mangala Rao
  • , Gary R. Matyas
  • , M. Gordon Joyce
    • Adrian H. Batchelor, Gregory D. Gromowski, Sheetij Dutta*
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology